These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 6194755

  • 1. [Combination chemotherapy (BEAM regimen) for head and neck cancer].
    Noguchi A, Inoue A, Kasai N, Uchida M.
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2158-62. PubMed ID: 6194755
    [Abstract] [Full Text] [Related]

  • 2. Treatment of advanced head and neck tumors with PEV-B regimen: a pilot study.
    Guaraldi M, Martoni A, Rossi AP, Romagnoli D, Occhiuzzi L, Caliceti U, Pannuti F.
    Chemioterapia; 1988 Oct; 7(5):341-4. PubMed ID: 2465095
    [Abstract] [Full Text] [Related]

  • 3. [Combination chemotherapy with methotrexate, vincristine, cis-platinum, cyclophosphamide, adriamycin, and bleomycin: MVP-CAB for disseminated urological cancer].
    Fujii A, Morishita S, Nakamura I, Oka Y, Ohshima H, Nagata H, Iwamoto T, Itoh N, Nakagawa Y, Miyazaki S.
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan 20; 25(1):55-62. PubMed ID: 1691254
    [Abstract] [Full Text] [Related]

  • 4. [Combined chemotherapy for head and neck cancer using cisplatin, methotrexate and continuous subcutaneous infusion of peplomycin].
    Kagami Y, Nishio M, Saitoh A, Doi Y, Asano K, Sakurai T, Murakami Y, Narimatsu N.
    Gan To Kagaku Ryoho; 1985 Feb 20; 12(2):337-42. PubMed ID: 2578770
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH, Mailliard JA, Suman VJ, Edmonson JH, Creagan ET, Nair S, Levitt R, Kugler JW.
    Cancer; 2002 Apr 15; 94(8):2224-31. PubMed ID: 12001121
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct 15; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM, Glisson BS, Khuri FR, Hong WK, Lippman SM.
    Semin Oncol; 1998 Apr 15; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
    [Abstract] [Full Text] [Related]

  • 12. Phase II trial of VP-16, bleomycin, and cisplatin in patients with advanced nonsquamous cell head and neck neoplasms.
    Creagan ET, Schutt AJ, Richardson RL, Schaid DJ.
    Am J Clin Oncol; 1993 Aug 15; 16(4):291-4. PubMed ID: 7687089
    [Abstract] [Full Text] [Related]

  • 13. [Neo-adjuvant chemotherapy of head and neck cancer].
    Bodemann H, Arnold H, Mann W, Hannich S, Kraft A, Löhr GW.
    Dtsch Med Wochenschr; 1986 Jul 11; 111(28-29):1097-100. PubMed ID: 2426076
    [Abstract] [Full Text] [Related]

  • 14. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R, Hornedo J, Colomer R, Mendiola C, Brandariz A, Sevilla E, Alvarez-Vicent J, Cortés-Funes H.
    Semin Oncol; 1995 Dec 11; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [Abstract] [Full Text] [Related]

  • 15. [A study of the use of methotrexate, vincristine, cis-platinum, cyclophosphamide, adriamycin, bleomycin (MVP-CAB) in metastatic transitional cell carcinoma].
    Fujii A, Den S, Nakamura I, Ohshima H, Nagata H, Izumi T, Takechi Y, Kawaida T, Kamidono S, Yasuno H.
    Hinyokika Kiyo; 1987 May 11; 33(5):697-703. PubMed ID: 2444083
    [Abstract] [Full Text] [Related]

  • 16. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
    Wagenaar HC, Colombo N, Vergote I, Hoctin-Boes G, Zanetta G, Pecorelli S, Lacave AJ, van Hoesel Q, Cervantes A, Bolis G, Namer M, Lhommé C, Guastalla JP, Nooij MA, Poveda A, Scotto di Palumbo V, Vermorken JB.
    Gynecol Oncol; 2001 Jun 11; 81(3):348-54. PubMed ID: 11371121
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
    Gobbi PG, Ghirardelli ML, Avanzini P, Baldini L, Quarta G, Stelitano C, Broglia C, Loni C, Silingardi V, Ascari E.
    Haematologica; 2000 Mar 11; 85(3):263-8. PubMed ID: 10702814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.